arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

STAAR SURGICAL CO

STAA
$19.79 ▼ -0.84 (-4.05%) at close
Industrials ·Ophthalmic Goods ·USOphthalmic Goods
68 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

STAAR SURGICAL CO faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $995.9M
Dividend Yield —
Revenue Growth 111.0% ↘
Op. Margin 10.8% ↗
ROIC 2.0% ↗
FCF / Share $0.38 ↗
Trailing P/E 123.7x
Price / Book 2.7x
FCF Yield 1.9%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$93.53M
↑ +111.0% —
Net Income Profit after all expenses
$8.06M
↑ +54.8% —
Operating Margin Operating profit as % of sales
10.8%
↑ +26.6% 6th
FCF / Share Free cash flow per share
$0.38
↑ +186.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
26
Cash Quality ↓
40

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters